Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2601-2612

  Weaver, A ^a   Chang, J ^b   Wrigley, E ^b   De Wynter, E ^b   Woll, P J ^b   Lind, M ^b   Jenkins, B ^b   Gill, C ^b   Wilkinson, P M ^b   Pettengell, R ^b   Radford, J A ^b   Collins, C D ^b   Dexter, T M ^b   Testa, N G ^b   Crowther, D ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ADULT; APHERESIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CELL MOTILITY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; STEM CELL;

EID: 0031879452     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2601     Document Type: Article

References (23)

1. Juttner CA, To LB, Roberts MM, et al: Comparison of haematological recovery, toxicity and supportive care of autologous PBSC, autologous BM and allogeneic BM transplants. Int J Cell Cloning 10:160-164, 1992
2. 2 in patients with advanced cancer. Aust NZ J Med 22:660-665, 1992
3. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339:640-644, 1992
4. Zsebo KM, Williams DA, Geissler EN, et al: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213-324, 1990
5. Andrews RG, Bensinger WI, Knitter GH, et al: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715-2720, 1992
6. Briddell RA, Hartley CA, Smith KA, et al: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720-1724, 1993
7. Andrews RG, Briddell RA, Knitter GH, et al: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor (G-CSF) in baboons enhanced circulation of progenitor cells. Blood 84:800-810, 1994
8. De Revel T, Applebaum FR, Storb R, et al: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795-3799, 1994
9. Crawford J, Lau D, Erwin R, et al: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients (pts) with advanced non-small cell lung carcinoma (NSCLC). Proc Am Soc Clin Oncol 12:135, 1993 (abstr 338)
10. Orazi A, Gordon MS, John K, et al: In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow toxicities. Am J Clin Pathol 103:177-184, 1995
11. Glaspy JA, Shpall EJ, LeMaistre CF, et al: Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90:2939-2951, 1997
12. Socinski MA, Cannistra SA, Elias A, et al: Granulocyte-macrophage colony-stimulating factor expands the circulating hemopoietic progenitor cell compartment in man. Lancet 1:1194-1198, 1988
13. Boiron JM, Marit G, Faberes C, et al: Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 12:49-55, 1993
14. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989
15. + colony-forming cell types in blood and marrow of baboons. Blood 80:920-927, 1992
16. Coutinho LH, Gilleece MH, De Wynter EA, et al: Clonal and long term cultures using human bone marrow, in Testa NG, Molineux G (eds): Haematology: A Practical Approach. Oxford, United Kingdom, Oxford University, 1993. pp 75-80
17. Siena S, Bregni M, Brando B, et al: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-409, 1991
18. Weaver A, Ryder D, Dexter TM, et al: Increasing numbers of long term culture-initiating cells (LTC-IC) are mobilized into the peripheral blood with increasing doses of stem cell factor (SCF) in combination with filgrastim (G-CSF) and chemotherapy. Exp Hematol 24:1041, 1996 (abstr 97)
19. Weaver A, Ryder D, Dexter TM, et al: Increased numbers of long term culture-initiating cells (LTC-IC) in the apheresis product of patients randomized to receive increasing doses of stem cell factor given in combination with chemotherapy and a standard dose of granulocyte colony stimulating factor. Blood 88:3323-3328, 1996
20. - cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316-2324, 1991
21. Avraham H, Vannier E, Cowley S, et al: Effects of the stem cell factor, c-kit ligand, on human megakaryocyte cells. Blood 79:365-371, 1992
22. Andrews RG, Briddell RA, Knitter GH, et al: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonprimates. Blood 85:15-20, 1995
23. Pettengell R, Woll PJ, Thatcher N, et al: Multicyclic, dose intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 13:148-152, 1996